Procter & Gamble completes game-changing acquisition of Merck’s consumer health unit
In a significant boost to its consumer health portfolio, Procter & Gamble (P&G) has concluded its €3.4 billion acquisition of German pharmaceutical giant Merck’s consumer ... Read More
EC approves Pelmeg: Mundipharma’s answer to chemotherapy-induced neutropenia
Mundipharma, a German pharmaceutical company, has achieved a significant milestone with the European Commission (EC)'s approval of Pelmeg, its pegylated biosimilar to Amgen’s Neulasta (pegfilgrastim). ... Read More
Spark Therapeutics’ Luxturna gains EU approval as first gene therapy for inherited retinal disease
In a significant breakthrough for treating inherited vision loss, Pennsylvania-based Spark Therapeutics has received European Commission (EC) approval for its pioneering gene therapy, Luxturna (voretigene ... Read More
Mylan launches Hulio, a biosimilar to Humira, across major European markets
Mylan has officially launched Hulio, its biosimilar to AbbVie’s Humira (adalimumab), across major European markets. This launch follows the European Commission's recent approval of Hulio ... Read More